Showing 1121-1130 of 3159 results for "".
Fat Chance
https://practicaldermatology.com/topics/general-topics/fat-chance/21037/Experts weigh in on today's non-invasive fat reduction techniques.The Next Big Thing: Aesthetics in 2016
https://practicaldermatology.com/topics/practice-management/the-next-big-thing-aesthetics-in-2016/21035/Industry leaders share their predictions for what we will be talking about this year in aesthetic dermatology.How to Evaluate EHRs in a Switcher's Market
https://practicaldermatology.com/topics/practice-management/how-to-evaluate-ehrs-in-a-switchers-market/21031/Six questions that can help potential users evaluate a product's value.Reach Your Customers
https://practicaldermatology.com/topics/practice-management/reach-your-customers/21079/Strategic messaging and marketing opportunities for your practice.Success Tips: Selling Great Aesthetic Value for a Fair Price
https://practicaldermatology.com/topics/practice-management/success-tips-selling-great-aesthetic-value-for-a-fair-price/21094/How to convey product or service value to patients to close a sale with confidence.Confessions of a Media Expert
https://practicaldermatology.com/topics/practice-management/confessions-of-a-media-expert/21128/An expert shares her top 5 pet peeves of working with doctors and traps to avoid to get ink.Currents
https://practicaldermatology.com/topics/practice-management/currents/21127/Top 10 Ways to Improve Acne Treatment
https://practicaldermatology.com/topics/practice-management/top-10-ways-to-improve-acne-treatment/21151/Tips for enhancing treatment regimens for better results.Pruritus: A Marker For Cancer?
https://practicaldermatology.com/topics/practice-management/pruritus-a-marker-for-cancer/21181/Though the relationship is well known, new studies validate concerns regarding the link between pruritus and malignancy.Biologics and Pediatric Psoriasis
https://practicaldermatology.com/topics/practice-management/biologics-and-pediatric-psoriasis/21196/Though data has been lacking in recent years, the use of biologics in pediatric and adolescent patients deserves more consideration.